EC Number   |
Inhibitors |
Structure |
|---|
   3.4.21.26 | ((8'Z)-pentadecenyl)-salicylic acid |
a noncompetitive inhibitor isolated from Gingko biloba leaves |
   |
| 3.4.21.26 | (+)-gallocatechin |
IC50: 0.000109 mM, expected to be useful for preventing and curing of Alzheimers disease |
|
| 3.4.21.26 | (-)-epicatechin |
IC50: 0.0281 mM, noncompetitive inhibition |
|
| 3.4.21.26 | (-)-epicatechin 3-O-gallate |
0.000052 mM, noncompetitive inhibition |
|
| 3.4.21.26 | (-)-epicatechin gallate |
IC50: 10.2 mM, expected to be useful for preventing and curing of Alzheimers disease |
|
| 3.4.21.26 | (-)-epigallocatechin gallate |
IC50: 0.000142 mM, expected to be useful for preventing and curing of Alzheimers disease |
|
| 3.4.21.26 | (1R,3S,4S,5S)-1,3,4-tris(acetyloxy)-5-([(2E)-3-[3,4-bis(acetyloxy)phenyl]prop-2-enoyl]oxy)cyclohexanecarboxylic acid |
81.9% inhibition at 0.5 mM |
|
| 3.4.21.26 | (1R,3S,4S,5S)-3-[[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1,4,5-trihydroxycyclohexanecarboxylic acid |
88% inhibition at 0.5 mM |
|
| 3.4.21.26 | (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid |
93.8% inhibition at 0.5 mM |
|
| 3.4.21.26 | (2E)-3-(3,4-dimethoxyphenyl)prop-2-enoic acid |
29.4% inhibition at 0.5 mM |
|
